BackGlucose Health Overview
Glucose Health, Inc.

Glucose Health Return on Equity

Valuation check: GLUC's ROE is -728.18%, below the sector sector average of 11.75%.

Get informed when a big investor buys or sells

+ Follow

ROE

-728.18%

Return on Equity

-728.18%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Glucose Health (GLUC) FAQ

Glucose Health (GLUC) currently reports a ROE of -728.18%. That is below the sector sector average of 11.75%. Use the charts on this page to explore Glucose Health's ROE history and peer comparisons.

Glucose Health's ROE of -728.18% is lower than the its sector sector average of 11.75%. That is roughly 6295.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Glucose Health's current -728.18% should be judged against industry norms (sector average: 11.75%) and against GLUC's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -728.18%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 11.75%. From there, open related valuation or income-statement pages for Glucose Health, and consider following GLUC for alerts when major investors trade the stock.